<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407377/" ref="ordinalpos=640&amp;ncbi_uid=4842847&amp;link_uid=PMC3407377" image-link="/pmc/articles/PMC3407377/figure/F2/" class="imagepopup">Fig. 2. Schema of TAK1 <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">pathway</span>.  From: TGF-? <span class="highlight" style="background-color:">signaling</span> via TAK1 <span class="highlight" style="background-color:">pathway</span>: Role in kidney fibrosis. </a></div><br /><div class="p4l_captionBody">Under unstimulated condition, TAK1 associates with TβRI through complex formation with TAB2 and TRAF6. Upon TGF-β1 stimulation and formation of TβRI-TβRII hetero-tetrameric complexes, autopolyubiqitination of TRAF6 leads to polyubiquitination (Ub) of TAK1, triggering release of TAK1 from the receptor complexes. TAK1 interacts with TAB1, which in turn induces autophosphorylation of TAK1. The activated TAK1 transmits TGF-β1 signal to downstream signaling pathways such as the MKK3-p38 or MKK4-JNK cascade, or is rapidly deactivated by phosphatase PP2A. TGF-β1-induced TAK1 activation occurs independent of TβRI kinase activity.</div></div>